Tuesday, January 22, 2013

Novartis wins EU backing for first meningitis B vaccine

Novartis wins EU backing for first meningitis B vaccine

An employee smokes a cigarette beside the logo of Swiss drugmaker Novartis AG in front of a plant in BaselZURICH (Reuters) - Novartis clinched European approval for the first vaccine against meningitis B, and will seek to sell the drug as soon as possible. "Novartis is working with health authorities to provide access to Bexsero as soon as possible," the Swiss drugmaker said in a statement on Tuesday. There is currently no approved vaccine offering broad protection against "MenB," this particular type of meningitis. Novartis won a European panel backing for Bexsero in November. ...



Source: news.yahoo.com

No comments:

Post a Comment